Hyperbaric Oxygen Therapy in Branch Retinal Artery Occlusion in a 15-Year-Old Boy with Methylenetetrahydrofolate Reductase Mutation

dc.contributor.authorCelebi, Ali Riza Cenk
dc.contributor.authorKadayifcilar, Sibel
dc.contributor.authorEldem, Bora
dc.date.accessioned2023-02-21T12:33:40Z
dc.date.available2023-02-21T12:33:40Z
dc.date.issued2015-01-01
dc.description.abstractPurpose. To report the efficacy of hyperbaric oxygen (HBO) therapy in a case of branch retinal artery occlusion (BRAO) in a 15-year-old boy. Methods. We report a 15-year-old boy with sudden loss of vision due to BRAO. Examination included laboratory evaluation for systemic risk factors. Follow-up exams included visual acuity, fundus examination, fundus fluorescein angiography, and visual field testing. HBO therapy was employed for treatment. Results. Medical history was positive for isolated glucocorticoid deficiency. Laboratory evaluation disclosed hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) mutation. The visual acuity 0.05 at presentation improved to 0.8 after 20 days of HBO therapy. There was no change on visual fields. Conclusion. In this pediatric case, HBO therapy was useful in the treatment of BRAO.
dc.description.volume2015
dc.identifier.doi10.1155/2015/640247
dc.identifier.urihttps://hdl.handle.net/11443/1551
dc.identifier.urihttp://dx.doi.org/10.1155/2015/640247
dc.identifier.wosWOS:000215198100050
dc.publisherHINDAWI LTD
dc.relation.ispartofCASE REPORTS IN OPHTHALMOLOGICAL MEDICINE
dc.titleHyperbaric Oxygen Therapy in Branch Retinal Artery Occlusion in a 15-Year-Old Boy with Methylenetetrahydrofolate Reductase Mutation
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hyperbaric Oxygen Therapy in Branch Retinal.pdf
Size:
2.39 MB
Format:
Adobe Portable Document Format

Collections